Provided by Tiger Trade Technology Pte. Ltd.

Centene

65.02
+0.88001.37%
Post-market: 64.87-0.1500-0.23%19:56 EDT
Volume:3.15M
Turnover:204.27M
Market Cap:32.12B
PE:-6.28
High:65.16
Open:64.07
Low:64.03
Close:64.14
52wk High:69.36
52wk Low:28.24
Shares:494.00M
Float Shares:464.00M
Volume Ratio:1.02
T/O Rate:0.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-10.3600
EPS(LYR):-13.5343
ROE:-20.36%
ROA:2.48%
PB:1.42
PE(LYR):-4.80

Loading ...

Bernstein Adjusts Centene Price Target to $79 From $68, Maintains Outperform Rating

MT Newswires Live
·
Aug 03

Centene Corp : Bernstein Raises Target Price to $79 from $68

THOMSON REUTERS
·
Aug 03

Centene Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 01

Shenzhen Han’s CNC Shareholders Back Capital and Governance Changes at 2026 EGM

TIPRANKS
·
Jul 31

Centene Corp. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 30

Centene's Strong Q2 Beat Overshadowed by Delayed Medicaid Margin Recovery, RBC Says

MT Newswires Live
·
Jul 29

Centene Corp - to Redeem $500 Million of 4.25% Notes Due 2027 on August 13, 2026 - SEC Filing

Reuters
·
Jul 29

Centene Corp - $568.70 Mln of 2027 Notes to Remain Outstanding After Redemption - SEC Filing

THOMSON REUTERS
·
Jul 29

Centene to Redeem USD 500 Million of 4.25% Notes Due 2027 on Aug. 13

Reuters
·
Jul 29

Truist Financial Keeps Their Buy Rating on Centene (CNC)

TIPRANKS
·
Jul 29

Centene is Maintained at Neutral by Baird

Dow Jones
·
Jul 29

Centene Corp : Truist Securities Raises Target Price to $80 from $78

THOMSON REUTERS
·
Jul 29

Centene price target raised to $80 from $75 at Barclays

TIPRANKS
·
Jul 29

Analysts Offer Insights on Healthcare Companies: Kuros Biosciences (OtherCSBTF), Centene (CNC) and Incyte (INCY)

TIPRANKS
·
Jul 29

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Centene (CNC) and Dyne Therapeutics (DYN)

TIPRANKS
·
Jul 29

U.S. Research ROUNDUP-Boeing, Coca-Cola, PayPal

Reuters
·
Jul 29

Health Care up After Centene Earnings - Health Care Roundup

Dow Jones
·
Jul 29

Centene Director Paul J. Diaz Files Initial Beneficial Ownership Statement

Reuters
·
Jul 29

Barclays Raises Centene Price Target to $80 From $75

MT Newswires Live
·
Jul 29

U.S. Stocks on the MOVE-Visa, CMS Energy, Ecolab

Reuters
·
Jul 29